share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

艾伯维公司 | 25-NSE:由交易所申报的注销已到期、已赎回、已兑付证券的通知
美股SEC公告 ·  06/03 11:31
Moomoo AI 已提取核心信息
The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
纽交所已通知证交会其意向将Biora Therapeutics,Inc.的全部证券从交易所摘牌。根据12d2-2(a)规则,此举将于2024年6月14日业务开始前完成。该证券已于2024年6月3日全部赎回、到期兑付或被赎回,当天即被暂停交易。该行动的有效性通知已向证交会提交,将于2024年5月31日下午4:00生效。
纽交所已通知证交会其意向将Biora Therapeutics,Inc.的全部证券从交易所摘牌。根据12d2-2(a)规则,此举将于2024年6月14日业务开始前完成。该证券已于2024年6月3日全部赎回、到期兑付或被赎回,当天即被暂停交易。该行动的有效性通知已向证交会提交,将于2024年5月31日下午4:00生效。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息